Previous studies showed that the stable suppression of eIF3a could increase cell doubling time and change cell sensitivity to various cycle regulators [15], indicating the pro-oncogenic role of eIF3a in tumor development [12, 16, 17]. The gene discussed is EIF3A; the disease is neoplasm.